BioSkryb is a venture-backed startup bringing new solutions for cellular heterogeneity, in both the research and clinical space studies, using a proprietary genome amplification system.
Location: United States, North Carolina, Durham
Phone: +1 919-370-0841
Total raised: $11.5M
Founded date: 2018
Investors 1
Date | Name | Website |
- | Anzu Partn... | anzupartne... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
09.01.2020 | Seed | $11.5M | - | vcnewsdail... |
Mentions in press and media 7
Date | Title | Description | Category | Author | Source |
02.07.2021 | CureVac g... | Malte Greune → Aiming to bo... | - | Alex Hoffm... | endpts.com... |
22.01.2020 | Industrial... | Advances in biology, biochemis... | Anzu Partn... | Jonathan S... | techcrunch... |
16.01.2020 | Genomic Am... | BioSkryb, a developer of genom... | - | - | pulse2.com... |
09.01.2020 | BioSkryb R... | BioSkryb, a Durham, N.C.-based... | USA | - | finsmes.co... |
09.01.2020 | Daily fund... | Sea Star Beachwear raised $1.2... | - | Kristin Ka... | vator.tv/n... |
09.01.2020 | Single Cel... | We use cookies on our website ... | - | - | anzupartne... |
09.01.2020 | BioSkryb I... | DURHAM, N.C., BioSkryb, a de... | - | - | vcnewsdail... |